Mechanism of Action of St John???s Wort in Depression, CNS Drugs, vol.3, issue.3, pp.539-562, 2003. ,
DOI : 10.2165/00023210-200317080-00001
Johanniskraut ??? Beitr??ge der Inhaltsstoffe zu Wirkmechanismen und Wirksamkeit, Wiener Medizinische Wochenschrift, vol.72, issue.Suppl 1, pp.356-361, 2007. ,
DOI : 10.1007/s10354-007-0440-8
Role of Hyperforin in the Pharmacological Activities of St. John's Wort, CNS Drug Reviews, vol.71, issue.Suppl 1, pp.203-218, 2004. ,
DOI : 10.1111/j.1527-3458.2004.tb00022.x
In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs, Psychopharmacology, vol.162, issue.2, pp.193-202, 2002. ,
DOI : 10.1007/s00213-002-1073-7
Hyperforin im Johanniskraut ? Hauptwirkstoff oder nur Leitsubstanz?, Dtsch Apoth Ztg, vol.138, pp.56-62, 1998. ,
Hyperforin in St. John???s wort drug interactions, European Journal of Clinical Pharmacology, vol.77, issue.2, pp.225-233, 2006. ,
DOI : 10.1007/s00228-006-0096-0
Determining hyperforin and hypericin content in eight brands of St. John's wort, Am J Health Syst Pharm, vol.59, pp.545-547, 2002. ,
Analysis of the hypericin and pseudohypericin content of commercially available St. John's wort preparations, Can J Clin Pharmacol, vol.10, pp.114-118, 2003. ,
Comparison of German St. John's Wort Products According to Hyperforin and Total Hypericin Content, Journal of the American Pharmaceutical Association (1996), vol.41, issue.4, pp.560-566, 2001. ,
DOI : 10.1016/S1086-5802(16)31280-3
Equivalence of St John??s wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depression, International Clinical Psychopharmacology, vol.15, issue.2, pp.61-68, 2000. ,
DOI : 10.1097/00004850-200015020-00001
Comparison of St John's wort and imipramine for treating depression: randomised controlled trial, BMJ, vol.321, issue.7260, pp.536-539, 2001. ,
DOI : 10.1136/bmj.321.7260.536
The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials, British Journal of Clinical Pharmacology, vol.67, issue.5, pp.512-526, 2006. ,
DOI : 10.1067/mcp.2002.124080
Drug Interactions with St John???s Wort, Drug Safety, vol.1, issue.3, pp.773-797, 2004. ,
DOI : 10.2165/00002018-200427110-00003
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4, Clinical Pharmacology & Therapeutics, vol.68, issue.6, pp.598-604, 2000. ,
DOI : 10.1067/mcp.2000.112240
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor, Proceedings of the National Academy of Sciences, vol.97, issue.13, pp.7500-7502, 2000. ,
DOI : 10.1073/pnas.130155097
St John's wort, a herbal antidepressant, activates the steroid X receptor, Journal of Endocrinology, vol.166, issue.3, pp.11-16, 2000. ,
DOI : 10.1677/joe.0.166R011
Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John???s wort, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.18, issue.6, pp.377-382, 2007. ,
DOI : 10.1007/s00210-007-0172-8
The extent of induction of CYP3A by St. John???s wort varies among products and is linked to hyperforin dose, European Journal of Clinical Pharmacology, vol.18, issue.1, pp.29-36, 2006. ,
DOI : 10.1007/s00228-005-0061-3
Hyperforin content determines the magnitude of the St John's wort???cyclosporine drug interaction, Clinical Pharmacology & Therapeutics, vol.76, issue.4, pp.330-340, 2004. ,
DOI : 10.1016/j.clpt.2004.07.004
No Relevant Interaction with Alprazolam, Caffeine, Tolbutamide, and Digoxin by Treatment with a Low-Hyperforin St John???s Wort Extract, Planta Medica, vol.71, issue.4, pp.331-337, 2005. ,
DOI : 10.1055/s-2005-864099
Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling, Clinical Pharmacology & Therapeutics, vol.329, issue.2, pp.298-304, 2007. ,
DOI : 10.1038/sj.clpt.6100054
Johanniskraut und dessen Zubereitungen, Dtsch Apoth Ztg, vol.137, pp.3753-3757, 1997. ,
Johanniskraut (Hypericum perforatum ): HPLC-Analyse der wichtigen Inhaltsstoffe und deren Variabilität in einer Population, Dtsch Apoth Ztg, vol.127, pp.1227-1230, 1987. ,
An improved GC/MS method for the determination of midazolam in human plasma [abstract], Int J Clin Pharmacol Ther, vol.4, p.560, 2003. ,
Effect of tadalafil on cytochrome P450 3A4?mediated clearance: Studies in vitro and in vivo, Clinical Pharmacology & Therapeutics, vol.77, issue.1, pp.63-75, 2005. ,
DOI : 10.1016/j.clpt.2004.09.006
Evaluation of the Drug Interaction Potential of Aplaviroc, a Novel Human Immunodeficiency Virus Entry Inhibitor, Using a Modified Cooperstown 5 + 1 Cocktail, The Journal of Clinical Pharmacology, vol.31, issue.5, pp.577-587, 2006. ,
DOI : 10.1177/0091270006287291
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity, Clinical Pharmacology & Therapeutics, vol.70, issue.4, pp.317-326, 2001. ,
DOI : 10.1016/S0009-9236(01)17221-8
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects, Clinical Pharmacology & Therapeutics, vol.73, issue.1, pp.41-50, 2003. ,
DOI : 10.1067/mcp.2003.10